SCHEMBL16301445

SCHEMBL16301445

CN1CCN(CCCOc2ccc(I)cc2)CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.66
NPC1 O15118 1/20 0.66
ALDH1A1 P00352 2/20 0.65
USP2 O75604 1/20 0.65
HPGD P15428 1/20 0.65
HRH3 Q9Y5N1 6/20 0.62
DRD3 P35462 1/20 0.61
PDE1A P54750 1/20 0.54
PDE1B Q01064 1/20 0.54
PDE1C Q14123 1/20 0.54
MAPK1 P28482 2/20 0.54
CYP1A2 P05177 1/20 0.54
CHRM2 P08172 1/20 0.54
CHRM1 P11229 1/20 0.54
HTR2A P28223 1/20 0.54
SCN1A P35498 1/20 0.54
HTR2B P41595 1/20 0.54
KCNH2 Q12809 1/20 0.54
SCN2A Q99250 1/20 0.54
SIGMAR1 Q99720 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL73562 0.86 HRH3 (0.72) HRH3PDE1APDE1BPDE1CKCNH2
SCHEMBL737990 0.85 HRH3 (0.75) HRH3PDE1APDE1BPDE1CKCNH2
SCHEMBL2819407 0.85 HRH3 (0.75) HRH3PDE1APDE1BPDE1CKCNH2
SCHEMBL8360712 0.85 RAB9A (0.68) RAB9ANPC1ALDH1A1USP2HPGD
SCHEMBL1776344 0.84 MEN1 (0.55) RAB9ANPC1ALDH1A1USP2HPGD
SCHEMBL10817906 0.83 RAB9A (0.76) RAB9ANPC1ALDH1A1USP2HPGD
SCHEMBL7945866 0.83 RAB9A (0.66) RAB9ANPC1ALDH1A1USP2HPGD
SCHEMBL12359053 0.83 USP2 (0.91) RAB9ANPC1ALDH1A1USP2HPGD
SCHEMBL76269 0.83 RAB9A (0.66) RAB9ANPC1ALDH1A1USP2HPGD
SCHEMBL19091219 0.83 RAB9A (0.79) RAB9ANPC1ALDH1A1USP2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732543-B1 TETRACYCLIC CARBOLINE DERATIVES FOR INHIBITING ANGIOGENESIS PTC THERAPEUTICS INC (US) 2017-05-10 EP disclosed
EP-2431369-A2 Carboline derivatives useful in the inhibition of angiogenesis PTC Therapeutics, Inc. (US) 2012-03-21 EP disclosed